Spectrum Pharmaceuticals, Inc.SPPINASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank27
5Y CAGR-35.9%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

5Y CAGR
-35.9%/yr
Long-term compound
Percentile
P27
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
2 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM$2.90M+61.8%
2022$1.79M-
2021$0.00-
2020$0.00-100.0%
2019$12.01M-55.1%
2018$26.76M-43.3%
2017$47.22M+31.7%
2016$35.84M+29.4%
2015$27.69M+2.4%
2014$27.04M-